In light of changing macro and sector-specific contexts, most psychedelics companies have had to adapt their operations over the past year. The intensity of such adaptation differs from company to company, but at a minimum it has entailed reigning in non-critical spending, in some cases going so far as to shelve pipeline assets indefinitely. In the most dire cases, companies have resorted to…


Previous articleMINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023
Next articlePT384 – Vital Psychedelic Conversations